Photo of Ayana GibbsAyana Gibbs


My current research programme investigates the impact of genetic variation on the cognitive effects of noradrenergic drugs. In collaboration with colleagues at the Universities of Sussex (Tamzin Ripley), Simon Ward & Pete Clifton), Nottingham (Marie-Christine Pardon), Oxford (Liz Tunbridge), NIMH (Jingshan Chen, Daniel Weinberger & Karen Berman) and the Institute of Psychiatry (Cathy Fernandes), we are investigating putative pro-cognitive effects of experimental alpha 2 adrenoceptor antagonists on models of cognitive impairment.